These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

910 related articles for article (PubMed ID: 21802369)

  • 21. Recent update on the heterogeneity of the Alzheimer's disease spectrum.
    Jellinger KA
    J Neural Transm (Vienna); 2022 Jan; 129(1):1-24. PubMed ID: 34919190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct tau PET patterns in atrophy-defined subtypes of Alzheimer's disease.
    Ossenkoppele R; Lyoo CH; Sudre CH; van Westen D; Cho H; Ryu YH; Choi JY; Smith R; Strandberg O; Palmqvist S; Westman E; Tsai R; Kramer J; Boxer AL; Gorno-Tempini ML; La Joie R; Miller BL; Rabinovici GD; Hansson O
    Alzheimers Dement; 2020 Feb; 16(2):335-344. PubMed ID: 31672482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retrospective analysis of Braak stage- and APOE4 allele-dependent associations between MR spectroscopy and markers of tau and neurodegeneration in cognitively unimpaired elderly.
    Chen AM; Gajdošík M; Ahmed W; Ahn S; Babb JS; Blessing EM; Boutajangout A; de Leon MJ; Debure L; Gaggi N; Gajdošík M; George A; Ghuman M; Glodzik L; Harvey P; Juchem C; Marsh K; Peralta R; Rusinek H; Sheriff S; Vedvyas A; Wisniewski T; Zheng H; Osorio R; Kirov II
    Neuroimage; 2024 Aug; 297():120742. PubMed ID: 39029606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resistance and resilience to Alzheimer's disease pathology are associated with reduced cortical pTau and absence of limbic-predominant age-related TDP-43 encephalopathy in a community-based cohort.
    Latimer CS; Burke BT; Liachko NF; Currey HN; Kilgore MD; Gibbons LE; Henriksen J; Darvas M; Domoto-Reilly K; Jayadev S; Grabowski TJ; Crane PK; Larson EB; Kraemer BC; Bird TD; Keene CD
    Acta Neuropathol Commun; 2019 Jun; 7(1):91. PubMed ID: 31174609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein E allelotype is associated with neuropathological findings in Alzheimer's disease.
    Kumar NT; Liestøl K; Løberg EM; Reims HM; Mæhlen J
    Virchows Arch; 2015 Aug; 467(2):225-35. PubMed ID: 25898889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased Alzheimer's disease neuropathology is associated with type 2 diabetes and ApoE ε.4 carrier status.
    Malek-Ahmadi M; Beach T; Obradov A; Sue L; Belden C; Davis K; Walker DG; Lue L; Adem A; Sabbagh MN
    Curr Alzheimer Res; 2013 Jul; 10(6):654-9. PubMed ID: 23627755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurofibrillary tangle pathology and Braak staging in chronic epilepsy in relation to traumatic brain injury and hippocampal sclerosis: a post-mortem study.
    Thom M; Liu JY; Thompson P; Phadke R; Narkiewicz M; Martinian L; Marsdon D; Koepp M; Caboclo L; Catarino CB; Sisodiya SM
    Brain; 2011 Oct; 134(Pt 10):2969-81. PubMed ID: 21903728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations between quantitative [
    Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM
    Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansion.
    Bieniek KF; Murray ME; Rutherford NJ; Castanedes-Casey M; DeJesus-Hernandez M; Liesinger AM; Baker MC; Boylan KB; Rademakers R; Dickson DW
    Acta Neuropathol; 2013 Feb; 125(2):289-302. PubMed ID: 23053135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genotype-related differences of hippocampal apolipoprotein E levels only in early stages of neuropathological changes in Alzheimer's disease.
    Glöckner F; Meske V; Ohm TG
    Neuroscience; 2002; 114(4):1103-14. PubMed ID: 12379263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of APOE ɛ4 and Plasma p-tau181 with Preclinical Alzheimer's Disease and Longitudinal Change in Hippocampus Function.
    Salami A; Adolfsson R; Andersson M; Blennow K; Lundquist A; Adolfsson AN; Schöll M; Zetterberg H; Nyberg L
    J Alzheimers Dis; 2022; 85(3):1309-1320. PubMed ID: 34924376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A generalizable data-driven model of atrophy heterogeneity and progression in memory clinic settings.
    Baumeister H; Vogel JW; Insel PS; Kleineidam L; Wolfsgruber S; Stark M; Gellersen HM; Yakupov R; Schmid MC; Lüsebrink F; Brosseron F; Ziegler G; Freiesleben SD; Preis L; Schneider LS; Spruth EJ; Altenstein S; Lohse A; Fliessbach K; Vogt IR; Bartels C; Schott BH; Rostamzadeh A; Glanz W; Incesoy EI; Butryn M; Janowitz D; Rauchmann BS; Kilimann I; Goerss D; Munk MH; Hetzer S; Dechent P; Ewers M; Scheffler K; Wuestefeld A; Strandberg O; van Westen D; Mattsson-Carlgren N; Janelidze S; Stomrud E; Palmqvist S; Spottke A; Laske C; Teipel S; Perneczky R; Buerger K; Schneider A; Priller J; Peters O; Ramirez A; Wiltfang J; Heneka MT; Wagner M; Düzel E; Jessen F; Hansson O; Berron D
    Brain; 2024 Jul; 147(7):2400-2413. PubMed ID: 38654513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regional distribution and maturation of tau pathology among phenotypic variants of Alzheimer's disease.
    Arezoumandan S; Xie SX; Cousins KAQ; Mechanic-Hamilton DJ; Peterson CS; Huang CY; Ohm DT; Ittyerah R; McMillan CT; Wolk DA; Yushkevich P; Trojanowski JQ; Lee EB; Grossman M; Phillips JS; Irwin DJ
    Acta Neuropathol; 2022 Dec; 144(6):1103-1116. PubMed ID: 35871112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Typical and atypical appearance of early-onset Alzheimer's disease: A clinical, neuroimaging and neuropathological study.
    Kawakatsu S; Kobayashi R; Hayashi H
    Neuropathology; 2017 Apr; 37(2):150-173. PubMed ID: 28093855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic influence of apolipoprotein E4 genotype on hippocampal morphometry: An N = 725 surface-based Alzheimer's disease neuroimaging initiative study.
    Shi J; Leporé N; Gutman BA; Thompson PM; Baxter LC; Caselli RJ; Wang Y;
    Hum Brain Mapp; 2014 Aug; 35(8):3903-18. PubMed ID: 24453132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential clinicopathologic and genetic features of late-onset amnestic dementias.
    Murray ME; Cannon A; Graff-Radford NR; Liesinger AM; Rutherford NJ; Ross OA; Duara R; Carrasquillo MM; Rademakers R; Dickson DW
    Acta Neuropathol; 2014 Sep; 128(3):411-21. PubMed ID: 24899141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia?
    Crum J; Wilson J; Sabbagh M
    Alzheimers Res Ther; 2018 Oct; 10(1):104. PubMed ID: 30285877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Olfactory involvement in aging and Alzheimer's disease: an autopsy study.
    Attems J; Lintner F; Jellinger KA
    J Alzheimers Dis; 2005 Apr; 7(2):149-57; discussion 173-80. PubMed ID: 15851853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct subtypes of Alzheimer's disease based on patterns of brain atrophy: longitudinal trajectories and clinical applications.
    Ferreira D; Verhagen C; Hernández-Cabrera JA; Cavallin L; Guo CJ; Ekman U; Muehlboeck JS; Simmons A; Barroso J; Wahlund LO; Westman E
    Sci Rep; 2017 Apr; 7():46263. PubMed ID: 28417965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cortical neuritic plaques and hippocampal neurofibrillary tangles are related to dementia severity in elderly schizophrenia patients.
    Rapp MA; Schnaider-Beeri M; Purohit DP; Reichenberg A; McGurk SR; Haroutunian V; Harvey PD
    Schizophr Res; 2010 Jan; 116(1):90-6. PubMed ID: 19896333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.